For instance, levels of circulating EV PD-L1 were associated with advanced head and neck cancer, metastatic melanoma and poor prognosis in pancreatic cancer, which indicates their usefulness as biomarkers for tumor progression [155,156]. Here, CD274 is linked to neoplasm.